To validate the expression pattern of PLOD2 in vitro, we firstly measured the mRNA and protein level of PLOD2 in RCC cell lines (786-O, 769-P, ACHN, OSRC, and CAKI-1) by RT-qPCR and western blotting. The gene discussed is LARP6; the disease is renal cell carcinoma.